Goetz H. Kloecker, M.D., MSPH, MBA

Education:Goetz H. Kloecker, M.D., MSPH, MBA

M.D., Technical University of Munich, 1990
Residency, Internal Medicine, University of Erlangen/Nuremberg, 1993
Residency, Internal Medicine, Free University of Berlin, 1994
Residency, Internal Medicine, University of Louisville, 1997
Board Re/Certified, American Board of Internal Medicine (ABIM), 1997/07/17
Fellowship, Medical Oncology and Hematology, 2003
Board Certified, ABIM, Hematology, 2004, recertified 2013
Board Certified, ABIM, Medical Oncology, 2004, recertified 2014
MSPH, University of Louisville, 2002
MBA, Morehead State University, 2005
Board Certified ABIM, Palliative Care Medicine, 2012
BLS certified, 2020
ACSL certified, 2022

Current Positions:

Professor of Medicine, Department of Medicine
Director, Thoracic Medical Oncology, Brown Cancer Center
Director, Hematology/Oncology Fellowship Program
Member, Brown Cancer Center

Contact Information:

Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202

Email: ghkloe01@louisville.edu

Research Description:

My clinical focus is on multi-disciplinary approaches to the treatment of thoracic cancers.  I work with surgical and radiation oncologists to ensure that my patients receive the most effective combination of treatment modalities and have access to the most innovative drugs for the treatment of cancer.
My research interests include clinical trials of new chemotherapeutics and targeted agents, identification of barriers to treatment, observational studies and studies on supportive care.  I collaborate with basic science researchers to facilitate translational research.

Recent/Notable Publications:

  1. Maharaj S, Chang S, Kloecker G, Chesney J, Redman R, Rojan A.  Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.  Thrombosis Research 2022 Sep;217:48-51.  doi: 10.1016/j.thromres.2022.07.006.  Epub 2022 Jul 14.  PMID: 35853370.
  2. Kloecker G, Nolan J, Korbee L, Calhoun R, Logan B, Flora D, Flora D, Hartman P.  Social distancing to avoid SARS-CoV-2 infection in cancer and noncancer patients.  Journal of Patient Safety 2022 Dec 1;18(8):788-792.  doi: 10.1097/PTS.0000000000001058.  Epub 2022 Jul 7.  PMID: 35797588.  PMCID: PMC9698080.
  3. Schneider G, Kaliappan A, Nguyen TQ, Buscaglia R, Brock GN, Hall MB, DeSpirito C, Wilkey DW, Merchant ML, Klein JB, Wiese TA, Rivas-Perez HL, Kloecker GH, Garbett NC.  The utility of differential scanning calorimetry curves of blood plasma for diagnosis, subtype differentiation and predicted survival in lung cancer.  Cancers (Basel) 2021 Oct 23;13(21):5326.  doi: 10.3390/cancers13215326.  PMID: 34771491.  PMCID: PMC8582427.
  4. Bhandari S, Dunlap N, Kloecker G.  Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer.  Journal of Thoracic Disease 2021 May;13(5):3230-3234.  doi: 10.21037/jtd-2019-rbmlc-04.  PMID: 34164215.  PMCID: PMC8182502.
  5. Kumar R, Castillero F, Bhandari S, Malapati S, Kloecker G.  The Hispanic Paradox in non-small cell lung cancer.  Hematology/Oncology & Stem Cell Therapy 2022 Jun 1;15(2):21-29.  doi: 10.1016/j.hemonc.2021.02.004.  PMID: 33775613.
  6. Bayley-Veloso R, Szabo YZ, Cash E, Zimmaro L, Siwik C, Kloecker G, Salmon P, van der Gryp K, Sephton SE.  The association between history of traumatic events and health-related quality of life among lung cancer patients.  Journal of Psychosocial Oncology 2020 Sep-Oct;38(5):627-634.  doi: 10.1080/07347332.2020.1780364.  Epub 2020 Jun 29.  PMID: 32597346.
  7. Bhandari S, Kumar R, Pham D, Gaskins J, Kloecker G.  Treatment timing in small cell lung cancer, a National Cancer Database Analysis.  American Journal of Clinical Oncology 2020 May;43(5):362-365.  doi: 10.1097/COC.0000000000000676.  PMID: 32011350.
  8. Pham D, Bhandari S, Pinkston C, Oechsli M, Kloecker G.  Lung Cancer Screening Registry reveals low-dose CT screening remains heavily underutilized.  Clinical Lung Cancer 2020 May;21(3):e206-e211.  doi: 10.1016/j.cllc.2019.09.002.  Epub 2019 Sep 26.  PMID: 32001154.
  9. Liu M, Tong Z, Ding C, Luo F, Wu S, Wu C, Albeituni S, He L, Hu X, Tieri D, Rouchka EC, Hamada M, Takahashi S, Gibb AA, Kloecker G, Zhang HG, Bousamra M 2nd, Hill BG, Zhang X, Yan J.  Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.  Journal of Clinical Investigation 2020 Apr 1;130(4):2081-2096.  doi: 10.1172/JCI131335.  PMID: 31945018.  PMCID: PMC7108920.
  10. Kumar R, Bhandari S, Kloecker GH.  Harlequin sign in Pancoast tumor.  Current Problems in Cancer 2020 Apr;44(2):100506.  doi: 10.1016/j.currproblcancer.2019.100506.  Epub 2019 Nov 1.  PMID: 31732238.